NMPA Approval

Compound Aminophenazone and Barbital Injection

Approval Number

国药准字H14023663

Company山西晋新双鹤药业有限责任公司

Registration Date

November 4, 2020

Drug Information

Generic Name

复方氨林巴比妥注射液

Dosage Form

注射剂

Strength

2ml∶氨基比林0.1g,安替比林40mg,巴比妥18mg

Drug Type

化学药品

Registration Date

November 4, 2020

Company Information

Applicant Company

Company Name山西晋新双鹤药业有限责任公司

Manufacturing Company

Company Name山西晋新双鹤药业有限责任公司

Company Address

山西省运城市夏县城北三里墩

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨林巴比妥注射液 - NMPA 批准文号 | MedPath